The following is from Children’s Health Defense.

A dispute over two federal contracts worth up to $1.24 billion for Pfizer Covid-19 vaccines has shifted from whether taxpayer money has already been spent to whether the agreements will ultimately be used.

The controversy began after publicly available federal contracting records, listed on SAM.gov, showed two CDC contract awards to Pfizer for pediatric and adult Covid-19 vaccines during fiscal years 2026 and 2027. The contracts have a combined potential value of about $1.24 billion.

Health Secretary Robert F. Kennedy Jr. disputed claims that the government had already spent the money, saying the agreements establish a framework for possible future purchases and that no decisions have been made.

“The claim that CDC has already spent $1.24 billion on COVID-19 vaccines is simply wrong.”
— Robert F. Kennedy Jr.

Kennedy said HHS and the CDC have not purchased Covid-19 vaccines for the upcoming respiratory season and have not decided whether future purchases will be made.

The article notes that several questions remain unanswered. Neither HHS nor the CDC has publicly said whether any funds have been obligated, whether any delivery orders have been issued or whether the contracts will ultimately be canceled or used. As of publication, the contract listings remained publicly available but were marked “inactive.”

Critics quoted in the article called for greater transparency about the contracts and future vaccine procurement.

“Americans deserve more than assurances, they deserve action.”
— Daniel O’Connor, TrialSite News

The article notes that federal contract awards do not necessarily mean taxpayer money has been spent. While the agreements authorize future purchases up to a specified amount, spending would generally occur only if the government places orders under the contracts.

As of publication, HHS and the CDC had not provided additional details beyond Kennedy’s public statement.

For more information, read the full article here.

The post HHS says no decision on $1.24 billion Pfizer Covid-19 vaccine contracts, questions persist appeared first on Sharyl Attkisson.

IPAK-EDU is grateful to Sharyl Attkisson as this piece was originally published there and is included in this news feed with mutual agreement. Read More